Epidemiology of Injuries in Elite Badminton Players: a Prospective Study (BADINSEP)

November 27, 2019 updated by: Joffrey DRIGNY, University Hospital, Caen

Objective: To determine the incidence and characteristics of injuries in elite badminton players over a competitive season.

Design: 12-months prospective cohort study Setting: The French National Institute of Sport, Expertise, and Performance (INSEP).

Participants: Twenty international elite badminton players Independent variables: The type, the location, the occurrence of the injury (match or training), the footwork type, the type of shot and the perceived fatigue were collected.

Main Outcome Measures: Injury incidence rates were calculated per 1000 hours of play (Hop).

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Caen, France, 14000
        • CHU Caen Normandie

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

All the international elite badminton players training at the at the French National Institute of Sport, Expertise, and Performance (INSEP)

Description

Inclusion Criteria:

  • Badminton players training at the at the French National Institute of Sport, Expertise, and Performance (INSEP)
  • Participant competing at an international level
  • Medical follow-up over the 12-months duration of the study

Exclusion Criteria:

  • Participant unable to speak and read French language
  • Participant under the age of 18
  • Lack of informed and signed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Injury incidence rates
Time Frame: Injury incidence rates were calculated per 1000 hours of play (Hop) over the 12-month prospective follow-up
Injury incidence rates were calculated per 1000 hours of play (Hop).
Injury incidence rates were calculated per 1000 hours of play (Hop) over the 12-month prospective follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Injury incidence rates according to gender
Time Frame: Injury incidence rates were calculated per 1000 hours of play (Hop) over the 12-month prospective follow-up
Injury incidence rates were calculated per 1000 hours of play (Hop) in male and female
Injury incidence rates were calculated per 1000 hours of play (Hop) over the 12-month prospective follow-up
Injury incidence rates according to discipline
Time Frame: Injury incidence rates were calculated per 1000 hours of play (Hop) over the 12-month prospective follow-up
Injury incidence rates were calculated per 1000 hours of play (Hop) in singles and doubles players
Injury incidence rates were calculated per 1000 hours of play (Hop) over the 12-month prospective follow-up
Injury incidence rates according to occurence
Time Frame: Injury incidence rates were calculated per 1000 hours of play (Hop) over the 12-month prospective follow-up
Injury incidence rates were calculated per 1000 hours of play (Hop) in match or training
Injury incidence rates were calculated per 1000 hours of play (Hop) over the 12-month prospective follow-up
Description of injuries according to location (on the body, n)
Time Frame: Description of the number of injuries according to location of the injury on the body (n) over the 12-month prospective follow-up
Number of injuries according to location of the injury (on the body, n)
Description of the number of injuries according to location of the injury on the body (n) over the 12-month prospective follow-up
Description of injuries according to type of the injury (n)
Time Frame: Description of injuries according to the type of the injury (structure: muscle, tendon, bone, nerve...) (n) over the 12-month prospective follow-up
Number of injuries according to type of the injury (n)
Description of injuries according to the type of the injury (structure: muscle, tendon, bone, nerve...) (n) over the 12-month prospective follow-up
Description of injuries according to location (on the body, % of all)
Time Frame: Description of the distribution of injuries according to location of the injury on the body (%) over the 12-month prospective follow-up
Distribution of injuries according to location of the injury (on the body, % of all)
Description of the distribution of injuries according to location of the injury on the body (%) over the 12-month prospective follow-up
Description of injuries according to type of the injury (% of all)
Time Frame: Description of the distribution of injuries according to the type of the injury (structure: muscle, tendon, bone, nerve...) (%) over the 12-month prospective follow-up
Distribution of injuries according to type of the injury (% of all)
Description of the distribution of injuries according to the type of the injury (structure: muscle, tendon, bone, nerve...) (%) over the 12-month prospective follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2016

Primary Completion (Actual)

December 1, 2016

Study Completion (Actual)

June 1, 2018

Study Registration Dates

First Submitted

November 23, 2019

First Submitted That Met QC Criteria

November 27, 2019

First Posted (Actual)

November 29, 2019

Study Record Updates

Last Update Posted (Actual)

November 29, 2019

Last Update Submitted That Met QC Criteria

November 27, 2019

Last Verified

November 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • BADINSEP

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sport Injury

3
Subscribe